Table 2.
Patterns of alcohol use disorder (AUD) medication prescriptions among patients initiating any medication within 30 days of the first index episode, with retention defined as being prescribed the classifying medication for at least 80% of the days over the 180 days following the index episode.
| Characteristic | Total, n = 35,027 | PLWH, n = 10,603 | Not HIV-infected, n = 24,424 | p value |
|---|---|---|---|---|
| Any AUD medication (not including topiramate) | ||||
| Initiation, n (%) | 359 (1.0) | 83 (0.78) | 276 (1.1) | <0.01 |
| Retention, n (%) | 49 (0.14) | 16 (0.15) | 33 (0.14) | 0.72 |
| Any AUD pharmacotherapy (including topiramate) | ||||
| Initiation, n (%) | 494 (1.4) | 107 (1.0) | 387 (1.6) | <0.01 |
| Retention, n (%) | 49 (0.14) | 16 (0.15) | 33 (0.14) | 0.72 |
| Naltrexone (PO) | ||||
| Initiation, n (%) | 218 (0.62) | 48 (0.45) | 170 (0.70) | <0.01 |
| Retention, n (%) | 27 (0.10) | 10 (0.10) | 17 (0.10) | 0.44 |
| Disulfiram | ||||
| Initiation, n (%) | 126 (0.36) | 28 (0.26) | 98 (0.40) | 0.05 |
| Retention, n (%) | 22 (0.06) | 6 (0.06) | 16 (0.07) | 0.76 |
| Acamprosate | ||||
| Initiation, n (%) | 22 (0.06) | 7 (0.07) | 15 (0.06) | 0.88 |
| Retention, n (%) | 0 (0) | 0 (0) | 0 (0) | n/a |
| Topiramate | ||||
| Initiation, n (%) | 137 (0.39) | 25 (0.24) | 112 (0.46) | <0.01 |
| Retention, n (%) | 0 (0) | 0 (0) | 0 (0) | n/a |